Improving Insulin Sensitivity by Non-invasive Brain Stimulation
NCT ID: NCT04420650
Last Updated: 2023-11-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
44 participants
INTERVENTIONAL
2020-05-26
2023-11-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Improving Insulin Sensitivity by Non-invasive Brain Stimulation in Persons With Insulin Resistance
NCT04052399
Effects of Age and Obesity on Brain Insulin Sensitivity
NCT04372849
Effect of GLP1 Receptor Agonist on Brain Insulin Responsiveness
NCT06487832
The Effect of Central Insulin on Insulin Sensitivity and Energy Metabolism
NCT01479075
Influence of Central Nervous Insulin Sensitivity on Insulin Secretion
NCT02870361
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Specific Objectives
1. Implement tDCS stimulation compared to sham stimulation in overweight and obese adults to assess the impact on eating behavior, cognition and metabolism.
2. Evaluate whether 3-day non-invasive brain stimulation of the hypothalamus-cognitive network has a causal effect on metabolism.
3. Evaluate whether 3-day non-invasive brain stimulation has a significant effect on brain functional connectivity and diffusion parameters.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Anodal tDCS
Anodal tDCS of the hypothalamus-cognitive network
transcranial direct current stimulation
anodal or cathodal transcranial direct current stimulation
Cathodal tDCS
Cathodal tDCS of the hypothalamus-cognitive network
transcranial direct current stimulation
anodal or cathodal transcranial direct current stimulation
Sham Stimulation
Double blind sham stimulation (ramp-up ramp-down stimulation will be applied in order to simulate the active condition without any further continuous administration of current)
transcranial direct current stimulation
anodal or cathodal transcranial direct current stimulation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
transcranial direct current stimulation
anodal or cathodal transcranial direct current stimulation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age between 20 to 66 years of age
* Waist circumference ≥ 80 cm for women, ≥ 94 cm for men
Exclusion Criteria
* Persons who cannot legally give consent
* Pregnancy or lactation
* History of severe mental or somatic disorders including neurological diseases (incl. epileptic seizures)
* Taking psychotropic drugs
* Previous bariatric surgery
* Acute infection within the last 4 weeks
* Hemoglobin values less than 12g/dl for women, less than 14 g/dl for men
* Current participation in a lifestyle intervention study or a pharmaceutical study
* Contradictions to a MRI measurement (e.g. metal implants)
20 Years
66 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
German Center for Diabetes Research
OTHER
University Hospital Tuebingen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Stephanie Kullmann, PhD
Role: PRINCIPAL_INVESTIGATOR
Univeristy of Tübingen, Germany
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Clinic Tübingen
Tübingen, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BRAINSTIM
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.